Federal award
ABBOTT MOLECULAR INC.
W81K0025CA008
Contract
Obligated and Ceiling
- Obligated (net)
- $1,239,477.43
- Ceiling (potential value, not spending)
- $5,804,820.62
- Current value
- $2,761,265.16
- Gross positive obligations
- $1,555,325.08
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT MOLECULAR INC. · NK5QDVJBHMN7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT MOLECULAR INC. · NK5QDVJBHMN7
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0025CA008
- Award type code
- D
- Actions
- 6 · Jun 27, 2025 to Jun 30, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 30, 2026 | FY2026 | P00005 | M | $0.00 | — |
| Jun 15, 2026 | FY2026 | P00004 | D | $33,530.75 | — |
| May 28, 2026 | FY2026 | P00003 | C | −$315,847.65 | — |
| Feb 2, 2026 | FY2026 | P00002 | B | $0.00 | — |
| Dec 3, 2025 | FY2026 | P00001 | C | $1,521,794.33 | — |
| Jun 27, 2025 | FY2025 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.